S&P 500
(0.11%) 5 254.35 points
Dow J
(0.12%) 39 807 points
Nasdaq
(-0.12%) 16 379 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(-0.04%) $0.926
USD/NOK
(-0.17%) $10.82
USD/GBP
(-0.11%) $0.791
USD/RUB
(-0.24%) $92.35

Realtime updates for Biofrontera AG [BFRA]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Last Updated31 Dec 1970 @ 19:00

-2.91% $ 2.67

Live Chart Being Loaded With Signals

Commentary (31 Dec 1970 @ 19:00):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Biofrontera AG, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for the treatment of dermatological conditions and diseases caused primarily by exposure to sunlight that results in sun damage to the skin...

Stats
Today's Volume 4 951.00
Average Volume 30 523.00
Market Cap 0.00
EPS $0 ( 2022-04-11 )
Last Dividend $0.104 ( 2021-02-24 )
Next Dividend $0 ( N/A )
P/E -4.35
ATR14 $0.324 (12.13%)

Volume Correlation

Long: 0.02 (neutral)
Short: -0.25 (neutral)
Signal:(42.752) Neutral

Biofrontera AG Correlation

10 Most Positive Correlations
SOHU0.914
CHB0.904
NWL0.904
CSSEP0.903
TSRI0.902
AOUT0.902
HPK0.9
BMRA0.897
MODV0.897
OGI0.895
10 Most Negative Correlations
APXI-0.914
WINV-0.908
FRSG-0.907
KAII-0.906
ZEUS-0.906
MLAI-0.905
MATW-0.904
ALSA-0.904
MSAC-0.903
PTOC-0.903

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Biofrontera AG Correlation - Currency/Commodity

The country flag 0.67
( moderate )
The country flag 0.62
( weak )
The country flag 0.00
( neutral )
The country flag 0.51
( weak )
The country flag 0.44
( neutral )
The country flag -0.81
( strong negative )

Biofrontera AG Financials

Annual 2020
Revenue: $30.35M
Gross Profit: $26.81M (88.35 %)
EPS: $-0.467
Q3 2021
Revenue: $5.38M
Gross Profit: $4.68M (87.01 %)
EPS: $-0.202
Q2 2021
Revenue: $7.62M
Gross Profit: $6.50M (85.41 %)
EPS: $-0.141
Q1 2021
Revenue: $5.48M
Gross Profit: $4.58M (83.56 %)
EPS: $-0.180

Financial Reports:

No articles found.

Biofrontera AG Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Biofrontera AG Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future
Information
First Dividend $0.0221 2020-03-18
Last Dividend $0.104 2021-02-24
Next Dividend $0 N/A
Payout Date 2021-03-04
Next Payout Date N/A
# dividends 2 --
Total Paid Out $0.126 --
Avg. Dividend % Per Year 0.19% --
Score 0.6 --
Div. Sustainability Score 0
Div.Growth Potential Score 0
Div. Directional Score 0 --
Next Divdend (Est)
(2025-01-06)
$0 Estimate 0.00 %
Dividend Stability
0.03 Very Bad
Dividend Score
0.60
Pay Frequency
Annually
Yearly Payout
Year Amount Yield
2020 $0.0221 0.22%
2021 $0.104 1.30%
2022 $0 0.00%
2023 $0 0.00%
2024 $0 0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for NASDAQ

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
OXLC Dividend Royal 2023-12-14 Monthly 14 10.00% 8.50
PSEC Dividend Royal 2023-12-26 Monthly 21 7.04% 8.50
SLVO Dividend Royal 2023-11-20 Monthly 12 10.77% 8.50
QYLD Dividend Royal 2023-11-20 Monthly 11 7.50% 8.50
OXSQ Dividend Diamond 2023-12-14 Monthly 21 9.10% 8.50
GAIN Dividend Royal 2023-12-04 Monthly 20 8.19% 8.50
GLDI Dividend Royal 2023-11-20 Monthly 12 7.15% 8.50
HRZN Dividend King 2023-12-18 Monthly 15 6.60% 8.45
USOI Dividend Royal 2023-11-20 Monthly 8 16.70% 8.28
PFLT Dividend King 2023-11-15 Monthly 14 6.50% 8.27

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-0.4291.500-8.58-10.00[0 - 0.5]
returnOnAssetsTTM-0.2311.200-7.70-9.24[0 - 0.3]
returnOnEquityTTM-1.5031.500-10.00-10.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM3.150.80010.008.00[1 - 3]
quickRatioTTM2.480.8000.09370.0750[0.8 - 2.5]
cashRatioTTM1.9971.5000.01740.0262[0.2 - 2]
debtRatioTTM0.423-1.5002.94-4.42[0 - 0.6]
interestCoverageTTM-2.471.000-2.03-2.03[3 - 30]
operatingCashFlowPerShareTTM-0.1022.00-0.0341-0.0683[0 - 30]
freeCashFlowPerShareTTM-0.1302.00-0.0651-0.130[0 - 20]
debtEquityRatioTTM3.24-1.50010.00-10.00[0 - 2.5]
grossProfitMarginTTM0.8831.00010.0010.00[0.2 - 0.8]
operatingProfitMarginTTM-0.2511.000-7.02-7.02[0.1 - 0.6]
cashFlowToDebtRatioTTM-0.1191.000-1.774-1.774[0.2 - 2]
assetTurnoverTTM0.5380.8009.757.80[0.5 - 2]
Total Score-0.244

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-5.291.000-0.6360[1 - 100]
returnOnEquityTTM-1.5032.50-10.00-10.00[0.1 - 1.5]
freeCashFlowPerShareTTM-0.1302.00-0.0434-0.130[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM-0.1022.00-0.0341-0.0683[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM-2.281.500-10.000[0.5 - 2]
operatingCashFlowSalesRatioTTM-0.09391.000-4.850[0.1 - 0.5]
Total Score-2.56

Biofrontera AG

Biofrontera AG, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for the treatment of dermatological conditions and diseases caused primarily by exposure to sunlight that results in sun damage to the skin. Its principal product is Ameluz, a prescription drug for the treatment of lesion-directed and field-directed actinic keratosis. The company also offers BF-RhodoLED lamp, a photodynamic therapy for lesion-directed and field-directed treatment of actinic keratosis; and Belixos, an over-the-counter line of skin care cosmetic products. In addition, it is developing Ameluz for the treatment of field cancerization and nodular basal cell carcinoma. Further, the company's product portfolio includes Xepi, a prescription antibiotic cream for the treatment of impetigo; and Aktipak, a generic drug for the treatment of acne. It offers its products primarily in the United States, Europe, and Israel. The company has a collaboration and partnership agreement with Maruho Co., Ltd. Biofrontera AG was founded in 1997 and is headquartered in Leverkusen, Germany.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators